Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

ResearcherID: KRQ-8650-2024

Activities

Collapse all

Works (3)

Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II–III triple negative breast cancer: a retrospective analysis

Journal of Cancer Research and Clinical Oncology
2024-06-05 | Journal article | Author
DOI: 10.1007/s00432-024-05738-x
Part of ISSN: 1432-1335
Contributors: Huibo Wang; Nana Zhang; Qi Sun; Ziqi Zhao; Hui Pang; Xiatian Huang; Ruifeng Zhang; Wenli Kang; Ming Shan
Source: Self-asserted source
Huibo Wang
grade
Preferred source (of 2)‎

The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2024-01-08 | Journal article | Author
DOI: 10.1007/s12094-023-03371-7
PMID: 38190034
Contributors: Huibo Wang; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Ming Shan
Source: Self-asserted source
Huibo Wang
grade
Preferred source (of 2)‎

CD19 (+) B Cell Combined with Prognostic Nutritional Index Predicts the Clinical Outcomes of Patients with Gastric Cancer Who Underwent Surgery

Cancers
2023-04-28 | Journal article
DOI: 10.3390/cancers15092531
Part of ISSN: 2072-6694
Contributors: Hao Sun; Huibo Wang; Hongming Pan; Yanjiao Zuo; Ruihu Zhao; Rong Huang; Yingwei Xue; Hongjiang Song
Source: Self-asserted source
Huibo Wang
How many people are using ORCID?